Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice

被引:196
作者
Lukyanov, AN [1 ]
Gao, ZG [1 ]
Mazzola, L [1 ]
Torchilin, VP [1 ]
机构
[1] Northeastern Univ, Bouve Coll Hlth Sci, Dept Pharmaceut Sci, Boston, MA 02115 USA
关键词
polyethelene glycol; phospholipid; CMC; polymeric micelles; tumor drug delivery;
D O I
10.1023/A:1020488012264
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this work is to study the potential of micelles prepared from amphiphilic polyethelene glycol/phosphatidylethanolamine (PEG-PE) conjugates as a particulate drug delivery system capable of accumulation in tumors via the enhanced permeability and retention (EPR) effect. Methods. Micelles were prepared from PEGs of different molecular lengths conjugated with PE. The micelles were characterized by fluorescence-based critical micellization concentration (CMC) measurements, dynamic light scattering, and HPLC. Blood clearance and tumor accumulation of In-111-labeled micelles were studied in mice with subcutaneously established Lewis lung carcinoma (LLC) and EL4 T lymphoma (EL4) tumors. Results. Various versions of PEG-PE conjugates with PEG blocks ranging from 750 to 5000 Da formed very stable low CMC micelles at all concentrations down to 10(-5) M. The size of the micelles varied between 7 and 35 nm depending on the length of the PEG block. Micelles remained intact after prolonged incubation with the blood serum. Upon intravenous administration into mice, the micelles demonstrated circulation longevity, and they efficiently and selectively accumulated in both subcutaneous Lewis lung carcinoma and EL4 T lymphoma tumors. Conclusions. PEG-PE conjugates form very stable, long-circulating micelles. These micelles efficiently accumulate in tumors in vivo and may potentially be used as a tumor-specific delivery system for poorly soluble anticancer drugs.
引用
收藏
页码:1424 / 1429
页数:6
相关论文
共 25 条
[1]   Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818 [J].
Allen, C ;
Yu, YS ;
Maysinger, D ;
Eisenberg, A .
BIOCONJUGATE CHEMISTRY, 1998, 9 (05) :564-572
[2]   LIPOSOME CIRCULATION TIME AND TUMOR TARGETING - IMPLICATIONS FOR CANCER-CHEMOTHERAPY [J].
GABIZON, AA .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :285-294
[3]  
GAO Z, IN PRESS NANO LETT
[4]   Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment [J].
Hobbs, SK ;
Monsky, WL ;
Yuan, F ;
Roberts, WG ;
Griffith, L ;
Torchilin, VP ;
Jain, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4607-4612
[5]   AMPHIPATHIC POLYETHYLENEGLYCOLS EFFECTIVELY PROLONG THE CIRCULATION TIME OF LIPOSOMES [J].
KLIBANOV, AL ;
MARUYAMA, K ;
TORCHILIN, VP ;
HUANG, L .
FEBS LETTERS, 1990, 268 (01) :235-237
[6]   ENHANCED TUMOR ACCUMULATION AND PROLONGED CIRCULATION TIMES OF MICELLE-FORMING POLY(ETHYLENE OXIDE-ASPARTATE) BLOCK COPOLYMER-ADRIAMYCIN CONJUGATES [J].
KWON, G ;
SUWA, S ;
YOKOYAMA, M ;
OKANO, T ;
SAKURAI, Y ;
KATAOKA, K .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (1-2) :17-23
[7]  
Kwon GS, 1998, CRIT REV THER DRUG, V15, P481
[8]   Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles [J].
La, SB ;
Okano, T ;
Kataoka, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (01) :85-90
[9]  
Lasic D. D., 1995, STEALTH LIPOSOMES
[10]  
Monsky WL, 1999, CANCER RES, V59, P4129